|
|
|
|
|
Indiana
|
|
0-5534
|
|
35-0160330
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|||
111 Congressional Boulevard, Carmel IN |
|
46032
|
||
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|||||
Securities registered pursuant to Section 12(b) of the Act:
|
||||||
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||||
Class A Common Stock, No Par Value
|
PTVCA
|
The Nasdaq Stock Market LLC
|
||||
Class B Common Stock, No Par Value
|
PTVCB
|
The Nasdaq Stock Market LLC
|
||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
(d) |
Exhibits.
|
● |
As a result of actions to improve underwriting profitability, gross premiums written declined from $148.9 million in the first
quarter of 2019 to $134.0 million in the first quarter of 2020.
|
●
|
The reported combined ratio was 104.2% for the first quarter of 2020 which was an improvement over the 108.0% combined ratio
for the prior year period. The improving quarterly combined ratio trend reflects the continuation of positive rate actions initiated in 2019 and non-renewals of certain risks. While it had a minimal impact on the current period loss
ratio, we did experience a reduction in reported claims during the last two weeks of March, which we attributed to reduced traffic density as a result of the COVID-19 pandemic.
|
●
|
Net investment income increased to $7.2 million for the first quarter of 2020 driven by an asset allocation shift to fixed income and higher
investment balances.
|
● |
Unrealized and realized investment losses recognized through the income statement were $27.8 million (pre-tax).
|
● |
Net loss of $22.2 million for the first quarter of 2020.
|
● |
Repurchased $1.8 million (126,764 shares) during the first quarter of 2020. These purchases are immediately accretive to book value per share,
given an average repurchase price of 65% of March 31, 2020 book value.
|
● |
Book value per share was $21.53, down $3.98 per share or 15.6% from December 31, 2019.
|
Three months ended
|
||||
March 31, 2020
|
||||
Net realized losses on investment, including impairments, within income statement
|
(4,828
|
)
|
||
Net unrealized losses on equity securities and limited partnership investments within income statement
|
(22,929
|
)
|
||
Net unrealized losses on fixed income securities recorded within other comprehensive income
|
(23,087
|
)
|
||
Total realized and unrealized investment losses (pre-tax)
|
(50,844
|
)
|
Three Months Ended
|
||||||||
March 31
|
||||||||
2020
|
2019
|
|||||||
Income (loss) before federal income tax expense (benefit)
|
$
|
(25,139
|
)
|
$
|
3,514
|
|||
Less: Net realized losses on investments
|
(4,827
|
)
|
(299
|
)
|
||||
Less: Net unrealized gains (losses) - equity securities and limited partnerships
|
(22,929
|
)
|
6,327
|
|||||
Income (loss) from core business operations
|
$
|
2,617
|
$
|
(2,514
|
)
|
|||
Less: Net investment income
|
7,236
|
6,232
|
||||||
Underwriting loss
|
$
|
(4,619
|
)
|
$
|
(8,746
|
)
|
Unaudited Condensed Consolidated Balance Sheets
|
||||||||
(in thousands, except per share data)
|
||||||||
March 31
|
December 31
|
|||||||
2020
|
2019
|
|||||||
Assets
|
||||||||
Investments 1:
|
||||||||
Fixed income securities (2020: $757,451; 2019: $783,047)
|
$
|
746,856
|
$
|
795,538
|
||||
Equity securities
|
70,320
|
76,812
|
||||||
Limited partnerships, at equity
|
7,981
|
23,292
|
||||||
Commercial mortgage loans
|
11,882
|
11,782
|
||||||
Short-term 2
|
1,000
|
1,000
|
||||||
838,039
|
908,424
|
|||||||
Cash and cash equivalents
|
89,318
|
67,851
|
||||||
Restricted cash and cash equivalents
|
10,813
|
21,037
|
||||||
Accounts receivable
|
89,510
|
111,762
|
||||||
Reinsurance recoverable
|
415,021
|
432,067
|
||||||
Other assets
|
94,009
|
86,306
|
||||||
Current federal income taxes
|
4,381
|
4,878
|
||||||
Deferred federal income taxes
|
11,004
|
2,035
|
||||||
$
|
1,552,095
|
$
|
1,634,360
|
|||||
Liabilities and shareholders' equity
|
||||||||
Reserves for losses and loss expenses
|
$
|
1,001,599
|
$
|
988,305
|
||||
Reserves for unearned premiums
|
70,686
|
74,810
|
||||||
Borrowings under line of credit
|
20,000
|
20,000
|
||||||
Accounts payable and other liabilities
|
154,427
|
186,929
|
||||||
1,246,712
|
1,270,044
|
|||||||
Shareholders' equity:
|
||||||||
Common stock-no par value
|
606
|
610
|
||||||
Additional paid-in capital
|
53,045
|
53,349
|
||||||
Accumulated other comprehensive income (loss)
|
(12,179
|
)
|
9,369
|
|||||
Retained earnings
|
263,911
|
300,988
|
||||||
305,383
|
364,316
|
|||||||
$
|
1,552,095
|
$
|
1,634,360
|
|||||
Number of common and common
|
||||||||
equivalent shares outstanding
|
14,183
|
14,279
|
||||||
Book value per outstanding share
|
$
|
21.53
|
$
|
25.51
|
||||
1 2020 & 2019 cost in parentheses
|
||||||||
2 Approximates cost
|
Unaudited Condensed Consolidated Statements of Operations
|
||||||||
(in thousands, except per share data)
|
||||||||
Three Months Ended
|
||||||||
March 31
|
||||||||
2020
|
2019
|
|||||||
Revenues
|
||||||||
Net premiums earned
|
$
|
109,659
|
$
|
110,013
|
||||
Net investment income
|
7,236
|
6,232
|
||||||
Commissions and other income
|
1,663
|
2,064
|
||||||
Net realized losses on investments, excluding impairment losses
|
(4,787
|
)
|
(39
|
)
|
||||
Impairment losses on investments
|
(40
|
)
|
(260
|
)
|
||||
Net unrealized gains (losses) on equity securities and limited partnership investments
|
(22,929
|
)
|
6,327
|
|||||
Net realized and unrealized gains (losses) on investments
|
(27,756
|
)
|
6,028
|
|||||
90,802
|
124,337
|
|||||||
Expenses
|
||||||||
Losses and loss expenses incurred
|
81,831
|
87,122
|
||||||
Other operating expenses
|
34,110
|
33,701
|
||||||
115,941
|
120,823
|
|||||||
Income (loss) before federal income tax expense (benefit)
|
(25,139
|
)
|
3,514
|
|||||
Federal income tax expense (benefit)
|
(2,983
|
)
|
766
|
|||||
Net income (loss)
|
$
|
(22,156
|
)
|
$
|
2,748
|
|||
Per share data - diluted:
|
||||||||
Loss before net gains (losses) on investments
|
$
|
(.02
|
)
|
$
|
(.14
|
)
|
||
Net gains (losses) on investments
|
(1.54
|
)
|
.32
|
|||||
Net income (loss)
|
$
|
(1.56
|
)
|
$
|
.18
|
|||
Reconciliation of shares outstanding:
|
||||||||
Average shares outstanding - basic
|
14,169
|
14,848
|
||||||
Dilutive effect of share equivalents
|
-
|
30
|
||||||
Average shares outstanding - diluted
|
14,169
|
14,878
|
Unaudited Condensed Consolidated Statements of Cash Flows
|
||||||||
(in thousands)
|
||||||||
Three Months Ended
|
||||||||
March 31
|
||||||||
2020
|
2019
|
|||||||
Net cash provided by (used in) operating activities
|
$
|
(1,312
|
)
|
$
|
11,405
|
|||
Investing activities:
|
||||||||
Purchases of available-for-sale investments
|
(82,641
|
)
|
(140,645
|
)
|
||||
Proceeds from sales or maturities
|
||||||||
of available-for-sale investments
|
79,640
|
68,975
|
||||||
Proceeds from sales of equity securities
|
5,480
|
9,169
|
||||||
Purchase of commercial mortgage loans
|
(368
|
)
|
(1,172
|
)
|
||||
Proceeds from commercial mortgage loans
|
72
|
-
|
||||||
Distributions from limited partnerships
|
14,636
|
17,214
|
||||||
Other investing activities
|
(369
|
)
|
(797
|
)
|
||||
Net cash provided by (used in) investing activities
|
16,450
|
(47,256
|
)
|
|||||
Financing activities:
|
||||||||
Dividends paid to shareholders
|
(1,426
|
)
|
(1,493
|
)
|
||||
Repurchase of common shares
|
(1,782
|
)
|
(468
|
)
|
||||
Net cash used in financing activities
|
(3,208
|
)
|
(1,961
|
)
|
||||
Effect of foreign exchange rates on cash and cash equivalents
|
(687
|
)
|
307
|
|||||
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents
|
11,243
|
(37,505
|
)
|
|||||
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period
|
88,888
|
170,811
|
||||||
Cash, cash equivalents and restricted cash and cash equivalents at end of period
|
$
|
100,131
|
$
|
133,306
|
Protective Insurance Corporation and Subsidiaries
|
||||||||
(In thousands, except share and per share data)
|
Three Months Ended
|
|||||||
March 31
|
||||||||
2020
|
2019
|
|||||||
Annualized
|
||||||||
Book value per share beginning of period
|
$
|
25.51
|
$
|
23.95
|
||||
Book value per share end of period
|
21.53
|
24.63
|
||||||
Change in book value per share
|
$
|
(3.98
|
)
|
$
|
0.68
|
|||
Dividends paid
|
0.10
|
0.10
|
||||||
Change in book value per share plus dividends paid
|
$
|
(3.88
|
)
|
$
|
0.78
|
|||
Total value creation 1
|
NM
|
13.0
|
%
|
|||||
Return on average shareholders' equity:
|
||||||||
Average shareholders' equity
|
334,850
|
361,076
|
||||||
Net income (loss)
|
(22,156
|
)
|
2,748
|
|||||
Less: Tax valuation allowance recognized in net income (loss)
|
(2,306
|
)
|
-
|
|||||
Less: Net realized and unrealized gains (losses) on investments, net of tax
|
(21,927
|
)
|
4,762
|
|||||
Income (loss) from core business operations, net of tax
|
2,077
|
(2,014
|
)
|
|||||
Return on net income (loss) 2
|
NM
|
3.0
|
%
|
|||||
Return on income (loss) from core business operations, net of tax 2
|
2.5
|
%
|
(2.2
|
%)
|
||||
Loss and LAE expenses incurred
|
$
|
81,831
|
$
|
87,122
|
||||
Net premiums earned
|
109,659
|
110,013
|
||||||
Loss and LAE ratio
|
74.6
|
%
|
79.2
|
%
|
||||
Other operating expenses
|
$
|
34,110
|
$
|
33,701
|
||||
Less: Commissions and other income
|
1,663
|
2,064
|
||||||
Other operating expenses, less commissions and other income
|
$
|
32,447
|
$
|
31,637
|
||||
Net premiums earned
|
109,659
|
110,013
|
||||||
Expense ratio
|
29.6
|
%
|
28.8
|
%
|
||||
Combined ratio 3
|
104.2
|
%
|
108.0
|
%
|
||||
Gross premiums written
|
$
|
134,006
|
$
|
148,893
|
||||
Net premiums written
|
109,234
|
115,322
|
||||||
1 Total Value Creation equals change in book value plus dividends paid, divided by beginning book value. Quarterly amounts have been annualized. Q1 2020 is not meaningful when annualized.
|
||||||||
2 Quarterly amounts have been annualized. Q1 2020 is not meaningful when annualized
|
||||||||
3 The combined ratio is calculated as ratio of losses and loss expenses incurred, plus other operating expenses, less commission and other income to net premiums earned.
|
+?"S^(%LK
MJRN_L>J:?+YMK<%=P!XRK#T.!67_ ,(GK^O:O877BN^T][6P?S8K6P1PLCCH
MSEOY=.U$)Q]V3>P3A+WHI;D?QA_Y$";_ *^(OYT[XOR2)\/KD(Q >:)7QW&[
M/\P*WO%_AT>*?#5SI7G"%Y"K1R%